Effect of Dry Powder Inhaler Resistance on the Inspiratory Flow Rates and Volumes of Cystic Fibrosis Patients of Six Years and Older-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Dry Powder Inhaler Resistance on the Inspiratory Flow Rates and Volumes of Cystic Fibrosis Patients of Six Years and Older

Published:2006-12 Issue:4 Volume:19 Page:456-465
ISSN:0894-2684
Container-title:Journal of Aerosol Medicine
language:en
Short-container-title:Journal of Aerosol Medicine

Author:

Tiddens H.A.¹,Geller D.E.²,Challoner P.³,Speirs R.J.³,Kesser K.C.²,Overbeek S.E.⁴,Humble D.²,Shrewsbury S.B.,Standaert T.A.³

Affiliation:

1. Department of Pediatric Pulmonology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.

2. Nemours Children's Clinic, Department of Pediatric Pulmonology, Orlando, Florida.

3. Chiron Corporation, Seattle, Washington (now Novartis).

4. Department of Pulmonology, Erasmus Medical Center, Rotterdam, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jam.2006.19.456

Reference28 articles.

1. Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis

2. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis

3. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

4. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis andPseudomonas aeruginosa infection

5. Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of dry powder inhalers to improve patient outcomes: it’s not just about the device;Expert Opinion on Drug Delivery;2024-03-03

2. Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection;International Journal of Pharmaceutics;2024-03

3. Levofloxacin dry powder inhaler for high dose delivery;Powder Technology;2024-01

4. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review;Journal of Clinical Medicine;2023-05-20

5. A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention;Frontiers in Immunology;2023-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3